APA (7th ed.) Citation

Suero-Abreu, G. A., Drobni, Z., Gongora, C. A., Silva, T. Q., Taron, J., Karady, J., . . . Neilan, T. G. (2023). ASSOCIATION BETWEEN IMMUNE CHECKPOINT INHIBITORS WITH ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS IN FEMALE PATIENTS WITH CANCER. Journal of the American College of Cardiology (JACC), 81, 2127. https://doi.org/10.1016/S0735-1097(23)02571-8

Chicago Style (17th ed.) Citation

Suero-Abreu, Giselle A., et al. "ASSOCIATION BETWEEN IMMUNE CHECKPOINT INHIBITORS WITH ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS IN FEMALE PATIENTS WITH CANCER." Journal of the American College of Cardiology (JACC) 81 (2023): 2127. https://doi.org/10.1016/S0735-1097(23)02571-8.

MLA (9th ed.) Citation

Suero-Abreu, Giselle A., et al. "ASSOCIATION BETWEEN IMMUNE CHECKPOINT INHIBITORS WITH ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS IN FEMALE PATIENTS WITH CANCER." Journal of the American College of Cardiology (JACC), vol. 81, 2023, p. 2127, https://doi.org/10.1016/S0735-1097(23)02571-8.